VectivBio Alternatives & Competitors
12 companies similar to VectivBio — Biotech company develops treatments for severe rare diseases, aims to become glo...
Companies similar to VectivBio
Ultragenyx
Going Beyond Every Day
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Berlin Institute of Health in der Charité
Aus Forschung wird Gesundheit
BridgeBio
We move at the speed of patient need.
Rival Readout
Competing with VectivBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NBE-Therapeutics AG
Next generation antibody drug conjugates
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Onena Medicines
AI-centric preclinical company discovering and developing novel biopharmaceuticals to trea...
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
About VectivBio
VectivBio is a Switzerland-based clinical-stage biotech company founded in 2019, focused on developing treatments for severe rare diseases. With a clear emphasis on a patient-centric approach, their mission is to address significant unmet medical needs by developing life-changing therapies. The company boasts a skilled...
GI Treatment Advancement, Pharmaceutical Development, Patient Outcome Improvement, Research & Development
GI Patients, Healthcare Providers, Hospitals, Medical Researchers
Rare Diseases, Clinical-Stage Biotech, Patient-Centric Approach, Orphan Conditions, Drug Development, Therapy Commercialization, Innovative Medicines, Spinout Company, Translational Research, Life-Changing Therapies, Severe Illnesses, Targeted Therapies, Medical Needs
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around VectivBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at VectivBio on 27 Jan 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.